Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Ribavirin Dosing Concerns Can Be Addressed In MedGuide – Geneva

Executive Summary

Any concerns about patient safety related to dosing of generic ribavirin products can be addressed in medication guides, Geneva maintains

You may also be interested in...



Vertex Hepatitis C Drug To Enter Phase IIb In ’04; NDA Filing As Early As ’06

Pivotal trials for Vertex' Hepatitis C treatment merimepodib could begin in 2004, CEO Joshua Boger, PhD, said

Vertex Hepatitis C Drug To Enter Phase IIb In ’04; NDA Filing As Early As ’06

Pivotal trials for Vertex' Hepatitis C treatment merimepodib could begin in 2004, CEO Joshua Boger, PhD, said

Ribavirin ANDAs Await ICN Petition; FDA Generic Rule Takes Effect

The delay in approval for generic versions of Schering-Plough's Rebetol (ribavirin) illustrates one limitation of FDA's revised Waxman/Hatch regulations

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042394

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel